Ibiayi Dagogo‐Jack
Massachusetts General Hospital(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer therapeutics and mechanisms, Cancer Genomics and Diagnostics, RNA modifications and cancer
Most-Cited Works
- → Tumour heterogeneity and resistance to cancer therapies(2017)3,630 cited
- → Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer(2016)1,131 cited
- → Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer(2018)335 cited
- → Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer(2018)303 cited
- → Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma(2020)294 cited
- → Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer(2017)258 cited
- → Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer(2020)220 cited
- → SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors(2018)200 cited
- → Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer(2016)195 cited
- → MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer(2020)191 cited